Barclays Initiates Alnylam Pharmaceuticals At Overweight By: Benzinga via Benzinga March 04, 2015 at 07:48 AM EST Analysts at Barclays initiated coverage on Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) with a Overweight rating. The target price ... Read More >> Related Stocks: Alnylam Pharmaceuticals